Healthcare provider profile · identity verified

Aaron Burkhardt, DO

Internal Medicine · SIOUX FALLS, SD · NPI 1013322205

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	381	95
Atorvastatin Calcium	Atorvastatin Calcium	358	86
Omeprazole	Omeprazole	308	89
Lisinopril	Lisinopril	275	73
Amlodipine Besylate	Amlodipine Besylate	246	70
Levothyroxine Sodium	Levothyroxine Sodium	230	48
Losartan Potassium	Losartan Potassium	200	56
Sertraline Hcl	Sertraline Hcl	180	47
Tamsulosin Hcl	Tamsulosin Hcl	180	47
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	169	51
Hydrochlorothiazide	Hydrochlorothiazide	162	53
Pantoprazole Sodium	Pantoprazole Sodium	160	43
Prednisone	Prednisone	147	107
Metformin Hcl Er	Metformin Hcl	131	36
Metoprolol Succinate	Metoprolol Succinate	127	36
Rosuvastatin Calcium	Rosuvastatin Calcium	126	34
Clonazepam	Clonazepam	113	22
Albuterol Sulfate Hfa	Albuterol Sulfate	112	50
Montelukast Sodium	Montelukast Sodium	110	26
Metformin Hcl	Metformin Hcl	108	25
Simvastatin	Simvastatin	103	29
Carvedilol	Carvedilol	102	25
Eliquis	Apixaban	102	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	102	25
Tramadol Hcl	Tramadol Hcl	100	30
Metoprolol Tartrate	Metoprolol Tartrate	96	24
Trazodone Hcl	Trazodone Hcl	91	20
Potassium Chloride	Potassium Chloride	88	22
Furosemide	Furosemide	87	27
Mirtazapine	Mirtazapine	87	23
Azithromycin	Azithromycin	73	65
Pravastatin Sodium	Pravastatin Sodium	73	17
Pregabalin	Pregabalin	73	12
Diclofenac Sodium	Diclofenac Sodium	70	36
Donepezil Hcl	Donepezil Hcl	69	17
Oxybutynin Chloride	Oxybutynin Chloride	68	26
Finasteride	Finasteride	66	16
Famotidine	Famotidine	62	20
Ozempic	Semaglutide	60	suppressed
Allopurinol	Allopurinol	59	15
Dicyclomine Hcl	Dicyclomine Hcl	59	20
Januvia	Sitagliptin Phosphate	58	15
Zolpidem Tartrate	Zolpidem Tartrate	58	15
Duloxetine Hcl	Duloxetine Hcl	57	20
Glimepiride	Glimepiride	55	15
Bupropion Xl	Bupropion Hcl	54	15
Escitalopram Oxalate	Escitalopram Oxalate	54	suppressed
Meloxicam	Meloxicam	54	16
Warfarin Sodium	Warfarin Sodium	54	12
Clopidogrel	Clopidogrel Bisulfate	53	18
Baclofen	Baclofen	52	suppressed
Lorazepam	Lorazepam	49	11
Sucralfate	Sucralfate	49	12
Glipizide	Glipizide	48	suppressed
Ropinirole Hcl	Ropinirole Hcl	48	11
Atenolol	Atenolol	47	suppressed
Fluticasone Propionate	Fluticasone Propionate	47	24
Primidone	Primidone	45	12
Triamcinolone Acetonide	Triamcinolone Acetonide	45	34
Buspirone Hcl	Buspirone Hcl	43	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	43	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	42	suppressed
Mounjaro	Tirzepatide	38	suppressed
Incruse Ellipta	Umeclidinium Bromide	37	suppressed
Chlorthalidone	Chlorthalidone	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	36	suppressed
Alendronate Sodium	Alendronate Sodium	35	suppressed
Cefdinir	Cefdinir	34	28
Ondansetron Hcl	Ondansetron Hcl	33	17
Amitriptyline Hcl	Amitriptyline Hcl	32	11
Labetalol Hcl	Labetalol Hcl	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Fenofibrate	Fenofibrate	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Celecoxib	Celecoxib	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Jardiance	Empagliflozin	29	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	11
Memantine Hcl	Memantine Hcl	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Alprazolam	Alprazolam	26	suppressed
Jantoven	Warfarin Sodium	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	11
Valproic Acid	Valproic Acid (As Sodium Salt)	26	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Ketoconazole	Ketoconazole	24	12
Valsartan	Valsartan	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Rexulti	Brexpiprazole	17	suppressed
Topiramate	Topiramate	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Vascepa	Icosapent Ethyl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Cephalexin	Cephalexin	16	13
Mupirocin	Mupirocin	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Diazepam	Diazepam	14	suppressed
Digoxin	Digoxin	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	11
Risperidone	Risperidone	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Acetazolamide	Acetazolamide	13	suppressed
Butrans	Buprenorphine	13	suppressed
Clozapine	Clozapine	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Haloperidol	Haloperidol	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	13	suppressed
Tadalafil	Tadalafil	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Zonisamide	Zonisamide	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	12	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Modafinil	Modafinil	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	12	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	12	suppressed
Tegretol Xr	Carbamazepine	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Verapamil Hcl	Verapamil Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Armodafinil	Armodafinil	11	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error